Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is GBX 2,298.33.
A number of research firms recently weighed in on JMAT. Deutsche Bank Aktiengesellschaft raised their price target on shares of Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the company a “buy” rating in a research report on Friday, May 29th. Jefferies Financial Group reissued a “restricted” rating on shares of Johnson Matthey in a research report on Friday, May 29th. UBS Group reissued a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research report on Friday, May 22nd. Finally, Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st.
Get Our Latest Analysis on JMAT
Johnson Matthey Stock Down 0.7%
Johnson Matthey (LON:JMAT – Get Free Report) last released its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. The company had revenue of GBX 1,257.30 billion for the quarter. Research analysts expect that Johnson Matthey will post 173.4112903 earnings per share for the current fiscal year.
Insider Activity
In other news, insider Liam Condon purchased 4,500 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were bought at an average cost of GBX 2,127 per share, with a total value of £95,715. Also, insider Alastair Judge acquired 14 shares of the stock in a transaction on Wednesday, June 10th. The stock was bought at an average cost of GBX 1,990 per share, for a total transaction of £278.60. Insiders purchased 11,470 shares of company stock valued at $24,671,344 over the last ninety days. Company insiders own 0.51% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
